Our C&D activities include:
The project aims to enhance chemical safety assessments by using biomedical research species (e.g. Drosophila melanogaster, C. Elegans, Daphnia Magna…) integrating diverse fields of knowledge such as evolutionary biology, and applying advanced computational methods to determine which chemicals are toxic using omics and grouping.
The ONTOX consortium aims to develop a functional and sustainable approach to advancing human risk assessment of chemicals without using animals, aligning with the principles of 21st-century toxicity testing, next-generation risk assessment (NGRA) and probabilistic risk assessment.
Bringing together 11 partners, this project aims to develop new tools for assessing the risks of complex real-life chemical mixtures to protect European citizens and the environment looking at endocrine disrupting substances.
This project aims to promote the adoption of New Approach Methodologies (NAMs) by providing concrete guidance, recommendations, and training resources for the effective validation, integration, and use of NAMs in assessing the safety and efficacy of chemicals and pharmaceuticals.
starts 1 February 2021
ends 31 July 2026
Grant Agreement: 965406
Budget €19 305 583,75
Coordinator: University of Birmingham, United Kingdom
📅 starts 1 May 2021
📅 ends 30 April 2026
🇪🇺 Grant Agreement: 963845
Budget €17 211 050
Coordinator Vrije Universiteit Brussel, Belgium
📅 starts 1 November 2021
📅 ends 31 October 2025
🇪🇺 Grant Agreement: 101036631
Budget € 4 471 092,50
Coordinator Danmarks Tekniske Universitet, Denmark
📅 starts December 2024
📅 ends May 2027
🇪🇺 Grant Agreement: 101191595
Budget € 2 049 890,00
Coordinator Ineris,
France
If you are interested in working with us – just send a message